The agency has also sent more than 340 warning letters to manufacturers and retailers. Read More
The debut follows strong performance of the brand during its pilot in Chicago. Read More
The availability of nicotine with minimal harm justifies a rethink of our approach to this drug.Read More
The FDA is processing applications for some 1 million non-tobacco nicotine products.Read More
The project explores how best to minimize the nicotine strength in vaping products.Read More
The agency will face greater pressure to prove it's authorized to pursue its agenda. Read More
Scientists, regulators and industry must work together to help change perceptions of nicotine.Read More
Once implemented, however, it would cause a significant decline of industry revenue. Read More
Policy Masterstroke or Political Quagmire?
Rules to reduce nicotine in cigarettes are back on the agenda.Read More
Implementation, however, will likely take many years. Read More
Recent Posts
- Weight-Loss Drugs Suppress Tobacco Cravings
- UKVIA Updates Suppliers on Changing U.K. Landscape
- Altria Reaffirms Guidance
- U.K. Misleading Public About Relative Risk: Gilchrist
- Former Researcher Sues KT&G Over E-cigarette Patents
- Diluted Diligence
- Sampoerna Profit Jumps by One Third
- EU Urged to Adopt Science-Based Strategy
- Social Media Linked to Youth Tobacco Use
- Kenya to Consult on New Health Warnings
- New President at PMFCT
- Civil Money Penalties for 22 Elfbar Sellers
- Brazil Agency Upholds Vaping Sales Ban
- Royal College Releases New E-cig Report
- NCLA Weighs in on Cigar Rules Litigation